No Picture
News

Fauna Bio and Novo Nordisk enter into Research Collaboration to Discover Novel Therapeutics for Obesity

By investigating patterns in animals, companies hope to find genetic insights to find treatments for prevalent human disease

BERKELEY, Calif., Jan. 13, 2020 /PRNewswire/ — Fauna Bio, developers of the largest and most accurately characterized hibern… […]

No Picture
News

Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab

Oncologie receives exclusive global license to develop and commercialize navicixizumab

LONDON and REDWOOD CITY, Calif. and BOSTON, Jan. 13, 2020 /PRNewswire/ — Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), “Mereo” or the “Company,” and Oncolo… […]

No Picture
News

Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab

Oncologie receives exclusive global license to develop and commercialize navicixizumab

LONDON and REDWOOD CITY, Calif. and BOSTON, Jan. 13, 2020 /PRNewswire/ — Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), “Mereo” or the “Company,” and Oncolo… […]

No Picture
News

Natera Announces Achievement of $55 Million In Pharma Contracts and Issuance of New Oncology Patents

Exceeds 2019 goal of $40-$50 million in cumulative contracts with pharmaceutical companies and extends leadership in ctDNA MRD

SAN CARLOS, Calif., Jan. 6, 2020 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, tod… […]

No Picture
News

An Agency of the U.S. Federal Government Selects Cloud-based ValGenesis VLMS to Digitalize Their Validation Lifecycle Processes

SAN FRANCISCO, Dec. 10, 2019 /PRNewswire/ — ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced that an Agency of the U.S. Federal Government has chosen ValGenesis’s cloud-based, 100% p… […]

No Picture
News

Icelandic Biotech Firm Selects ValGenesis’s Cloud-Based Electronic Validation Lifecycle Management System For a Paperless Validation Process

SAN FRANCISCO, Nov. 26, 2019 /PRNewswire/ — ValGenesis, Inc., a market leader in Validation Lifecycle Management Systems (VLMS), announced today that an Iceland-based biotech firm has selected ValGenesis’s VLMS as their platform for validation proc… […]

No Picture
News

Kindred Biosciences Awarded a Contract by the National Cancer Institute in Support of the PREVENT Cancer Program

SAN FRANCISCO, Sept. 10, 2019 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company developing novel drugs and biologics, today announced that it has been selected by the National Cancer Institute (NCI… […]